SXPCX
Price
$48.78
Change
+$0.50 (+1.04%)
Updated
Jun 6 closing price
Net Assets
1.37B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

SXPCX vs VITSX

Header iconSXPCX vs VITSX Comparison
Open Charts SXPCX vs VITSXBanner chart's image
DWS S&P 500 Index C
Price$48.78
Change+$0.50 (+1.04%)
VolumeN/A
Net Assets1.37B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
SXPCX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SXPCX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SXPCX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. SXPCX (1.37B). VITSX pays higher dividends than SXPCX: VITSX (1.29) vs SXPCX (0.07). SXPCX was incepted earlier than VITSX: SXPCX (20 years) vs VITSX (28 years). SXPCX (1.26) is less costly to investors than VITSX (0.03). SXPCX (2.00) and VITSX (2.00) have comparable annual turnover. SXPCX has a lower initial minimum investment than VITSX: SXPCX (1000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. SXPCX (6.25). VITSX return over 5 years is better than : 80.96 vs. SXPCX (47.11).
SXPCXVITSXSXPCX / VITSX
Total Expense Ratio1.260.034,200%
Annual Report Gross Expense Ratio1.260.034,200%
Fund Existence20 years28 years-
Gain YTD0.9930.833119%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B1.82T0%
Annual Yield % from dividends0.071.295%
Returns for 1 year6.2510.9757%
Returns for 3 years24.6240.3561%
Returns for 5 years47.1180.9658%
Returns for 10 years92.60180.4951%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.